CRP and neoplasm: C-reactive protein (CRP), a key acute-phase reactant, independently predicts prognosis in many malignancies; its elevation accelerates angiogenesis through increased vascular growth factors and interleukins, thereby promoting tumor progression and decreased survival [7-9].